VAV1 and acute myeloid leukemia: Consistent with RE9a-induced AML mouse model, the survival time of Vav1-Cre;Phf6fl/y,MA9 (VC Phf6,MA9) mice was longer than that of Phf6fl/y,MA9 (WT Phf6,MA9) mice (Fig. 2I).